Dr Tina Carita Loven, DO | |
219 N Broad Street, 7th Floor, Philadelphia, PA 19107-1519 | |
(844) 464-6387 | |
(215) 239-3037 |
Full Name | Dr Tina Carita Loven |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 219 N Broad Street, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306074109 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | OS019878 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Tina Carita Loven, DO One Medical Center Blvd., Acp, Suite 232, Upland, PA 19013-3902 Ph: (844) 464-6387 | Dr Tina Carita Loven, DO 219 N Broad Street, 7th Floor, Philadelphia, PA 19107-1519 Ph: (844) 464-6387 |
News Archive
An ultrasensitive test has been developed that detects a corrupted protein associated with Alzheimer's disease and chronic traumatic encephalopathy, a condition found in athletes, military veterans, and others with a history of repetitive brain trauma.
The New England Journal of Medicine and Nature has published the first findings from the Cancer Research UK-funded Tracking Cancer Evolution through Treatment (Rx), TRACERx, lung cancer study, which reveals the increase in the risk of cancer relapse when lung tumors have unstable chromosomes.
Dr. Marie Kmita and her research team at the IRCM contributed to a multidisciplinary research project that identified the mechanism responsible for generating our fingers and toes, and revealed the importance of gene regulation in the transition of fins to limbs during evolution.
A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect against advanced and metastatic cancers in mice, according to a Mayo Clinic study, published in the July 12 edition of the online journal Oncotarget.
The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.
› Verified 6 days ago
Xun Li, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-316-5151 | |
Dr. Ahmet Fatih Atik, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Cotton St, Philadelphia, PA 19127 Phone: 215-892-7600 | |
Richard Schmidt, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 Walnut St Fl 2, Philadelphia, PA 19107 Phone: 215-955-7000 Fax: 215-503-7038 | |
Dr. Srinivasa Prasad Venkata Kanuparthi, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 | |
John Y Lee, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 3 Silverstein Bldg, Philadelphia, PA 19104 Phone: 215-662-3487 | |
Dr. Nduka Mgbechinyere Amankulor, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Civic Center Blvd, 2nd Flr South Pavilion, Philadelphia, PA 19104 Phone: 215-662-3487 Fax: 215-349-5534 | |
Kareem Amir Zaghloul, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104 Phone: 215-662-3957 |